HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiichi Tanaka Selected Research

Rheumatoid Arthritis

5/2024Factors contributing to the improvement in J-HAQ after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).
3/2024Prevalence of high and low serum alkaline phosphatase levels and the associated factors in patients with rheumatoid arthritis: results from the IORRA cohort study.
9/2023Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
8/2023Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: post-hoc subgroup analyses of the Japanese real-world observational "ORIGAMI" study.
7/2023Evaluation of RABBIT risk score in Japanese patients with rheumatoid arthritis starting first bDMARDs: a validation study using the IORRA cohort data.
5/2023Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).
3/2023Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study.
10/2022Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study.
8/2022Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study).
7/2022Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiichi Tanaka Research Topics

Disease

62Rheumatoid Arthritis
05/2024 - 04/2002
56Neoplasms (Cancer)
04/2024 - 01/2002
20Prostatic Neoplasms (Prostate Cancer)
05/2021 - 03/2002
12Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2023 - 03/2002
10Infections
07/2023 - 01/2005
10Tongue Neoplasms (Tongue Neoplasm)
02/2022 - 03/2002
8Pain (Aches)
09/2023 - 12/2005
8Carcinoma (Carcinomatosis)
05/2022 - 01/2003
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2003
7Neoplasm Metastasis (Metastasis)
12/2018 - 01/2006
4Adenocarcinoma
01/2022 - 09/2011
4Hemorrhage
05/2020 - 10/2003
4Thrombosis (Thrombus)
01/2020 - 01/2002
4Stomach Neoplasms (Stomach Cancer)
12/2019 - 12/2009
4Lymphatic Metastasis
12/2018 - 01/2004
4Pathologic Constriction (Stenosis)
07/2015 - 09/2013
4Klatskin Tumor
08/2014 - 01/2007
4Breast Neoplasms (Breast Cancer)
11/2011 - 05/2005
3Vasculitis (Vasculitides)
08/2022 - 01/2019
3Vitamin D Deficiency
01/2021 - 07/2013
3Neoplasms, Cystic, Mucinous, and Serous
12/2017 - 01/2004
3Inflammation (Inflammations)
11/2016 - 01/2007
3Vaginal Neoplasms (Cancer, Vaginal)
03/2015 - 08/2005
3Gallbladder Neoplasms (Gallbladder Cancer)
02/2015 - 01/2007
3Cholangiocarcinoma
06/2014 - 01/2005
3Systemic Scleroderma (Systemic Sclerosis)
06/2011 - 09/2002
2Wounds and Injuries (Trauma)
02/2023 - 12/2003
2Osteoporosis
01/2021 - 06/2020
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2020 - 01/2013
2Edema (Dropsy)
12/2019 - 02/2017
2Liver Failure
01/2017 - 07/2010
2Endometrial Neoplasms (Endometrial Cancer)
11/2016 - 05/2014
2Uterine Neoplasms (Uterine Cancer)
07/2015 - 01/2012
2Telangiectasis (Telangiectasia)
08/2014 - 12/2013
2Erythema
12/2013 - 01/2007
2Dermatitis
11/2011 - 11/2010
2Interstitial Lung Diseases (Interstitial Lung Disease)
06/2011 - 01/2004
2Fatigue
12/2009 - 06/2007
2Ulcer
01/2007 - 01/2005
2Esophageal Neoplasms (Esophageal Cancer)
05/2005 - 03/2002
1Cognitive Dysfunction
02/2024
1Sarcopenia
09/2023
1Lymphoma (Lymphomas)
06/2023
1Lung Neoplasms (Lung Cancer)
06/2023
1Cardiovascular Diseases (Cardiovascular Disease)
06/2023

Drug/Important Bio-Agent (IBA)

20Methotrexate (Mexate)FDA LinkGeneric
02/2024 - 04/2002
19Antirheumatic Agents (DMARD)IBA
05/2024 - 12/2002
10tocilizumab (atlizumab)FDA Link
01/2021 - 02/2012
9ametantrone (HAQ)IBA
05/2024 - 12/2005
8Abatacept (Orencia)FDA Link
05/2024 - 09/2014
5Adrenal Cortex Hormones (Corticosteroids)IBA
09/2023 - 02/2012
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2023 - 01/2005
4Adalimumab (Humira)FDA Link
05/2018 - 04/2011
3cyclic citrullinated peptideIBA
05/2023 - 05/2011
3hydroxide ionIBA
01/2021 - 07/2013
3Infliximab (Remicade)FDA Link
01/2020 - 03/2017
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2019 - 10/2003
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2011 - 02/2002
2omega-Chloroacetophenone (Mace)IBA
06/2023 - 10/2016
2Peroxidase (Myeloperoxidase)IBA
08/2022 - 10/2003
2Anti-Citrullinated Protein AntibodiesIBA
01/2022 - 05/2011
2Prednisolone (Predate)FDA LinkGeneric
05/2020 - 06/2011
2SteroidsIBA
01/2020 - 12/2011
2SiliconIBA
12/2019 - 03/2014
2GemcitabineFDA Link
11/2019 - 06/2007
2AndrogensIBA
03/2019 - 10/2014
2Cisplatin (Platino)FDA LinkGeneric
12/2018 - 08/2006
2Etanercept (Enbrel)FDA Link
05/2018 - 03/2017
2MucinsIBA
12/2017 - 01/2005
2fostamatinibIBA
01/2017 - 10/2016
2perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
08/2014 - 02/2011
2MetalsIBA
03/2014 - 01/2014
2CAM 5.2 antigenIBA
01/2011 - 07/2010
2Sulfasalazine (Azulfidine)FDA LinkGeneric
12/2002 - 12/2002
1Alkaline PhosphataseIBA
03/2024
1C-Reactive ProteinIBA
08/2023
1Peptides (Polypeptides)IBA
05/2023
1Anti-Bacterial Agents (Antibiotics)IBA
02/2023
1Janus Kinase InhibitorsIBA
10/2022

Therapy/Procedure

51Brachytherapy
04/2024 - 01/2002
30Radiotherapy
05/2022 - 03/2002
26Therapeutics
04/2024 - 02/2002
15Hepatectomy
01/2017 - 01/2002
10Pancreatectomy
03/2014 - 03/2003
8Drug Therapy (Chemotherapy)
11/2019 - 05/2005
6Aftercare (After-Treatment)
02/2017 - 03/2004
5Pancreaticoduodenectomy
01/2007 - 01/2003
4Chemoradiotherapy
06/2023 - 08/2006
3Re-Irradiation
04/2024 - 12/2013
3Gastrectomy
12/2019 - 12/2009
3Adjuvant Chemotherapy
11/2011 - 12/2009
2Neoadjuvant Therapy
01/2022 - 11/2019
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2019 - 09/2018
2Complementary Therapies (Alternative Medicine)
07/2013 - 01/2006
2Laparotomy
05/2012 - 06/2007
2Stents
09/2011 - 01/2002
2Esophagectomy
04/2011 - 01/2004
2Operative Surgical Procedures
07/2007 - 01/2004
1Biological Therapy
07/2023
1Catheters
06/2023